However, COX-2 inhibition did not reduce dyskinesia or COX-2 and FosB/ΔFosB expression, while significantly lowering PGE2 levels and oxidative stress in mouse and primate PD models [95]. The gene discussed is FOSB; the disease is Dyskinesia.